Adheris Health Limited (ASX:AHE)
Australia · Delayed Price · Currency is AUD 0.0210
-0.0020 (-8.70%)
At close: Mar 4, 2026
Adheris Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 40.6 | 62.99 | 98.4 | 97.96 | 67.75 | 38.77 |
| 40.6 | 62.99 | 98.4 | 97.96 | 67.75 | 38.77 | |
Revenue Growth (YoY) | -64.03% | -35.98% | 0.45% | 44.59% | 74.74% | 303.77% |
Cost of Revenue | 47.08 | 59.02 | 78.61 | 81.18 | 71.15 | 46.43 |
Gross Profit | -6.48 | 3.97 | 19.79 | 16.78 | -3.4 | -7.66 |
Selling, General & Admin | 11.02 | 10.71 | 12.14 | 13.24 | 2.66 | 2.53 |
Other Operating Expenses | 4.3 | 3.13 | 4.57 | 5.22 | 5.24 | 4.93 |
Operating Expenses | 17.25 | 17.03 | 20.22 | 23.81 | 12.79 | 10.67 |
Operating Income | -23.73 | -13.06 | -0.43 | -7.03 | -16.19 | -18.33 |
Interest Expense | -5.31 | -2.87 | -1.93 | -2.13 | -1.54 | -0.41 |
Interest & Investment Income | 0.13 | 0.08 | 0.16 | 0.05 | 0 | 0.04 |
Other Non Operating Income (Expenses) | -0 | - | - | - | - | 1.47 |
EBT Excluding Unusual Items | -28.9 | -15.85 | -2.21 | -9.11 | -17.73 | -17.23 |
Merger & Restructuring Charges | -0.92 | -0.92 | - | -1.4 | - | - |
Asset Writedown | -46.54 | -46.54 | - | - | - | - |
Pretax Income | -58.88 | -63.31 | -2.21 | -10.52 | -17.73 | -17.23 |
Income Tax Expense | -0.79 | 0.01 | 0.13 | 0.79 | -0.24 | -2.86 |
Earnings From Continuing Operations | -58.09 | -63.32 | -2.34 | -11.31 | -17.49 | -14.37 |
Earnings From Discontinued Operations | 3.83 | 3.11 | 3.13 | - | - | - |
Net Income to Company | -54.26 | -60.21 | 0.79 | -11.31 | -17.49 | -14.37 |
Minority Interest in Earnings | - | - | - | - | 0.14 | 0.42 |
Net Income | -54.26 | -60.21 | 0.79 | -11.31 | -17.35 | -13.95 |
Net Income to Common | -54.26 | -60.21 | 0.79 | -11.31 | -17.35 | -13.95 |
Shares Outstanding (Basic) | 599 | 566 | 548 | 545 | 378 | 317 |
Shares Outstanding (Diluted) | 599 | 566 | 597 | 545 | 378 | 317 |
Shares Change (YoY) | 9.05% | -5.29% | 9.57% | 44.12% | 19.47% | 36.47% |
EPS (Basic) | -0.09 | -0.11 | 0.00 | -0.02 | -0.05 | -0.04 |
EPS (Diluted) | -0.09 | -0.11 | 0.00 | -0.02 | -0.05 | -0.04 |
Free Cash Flow | -14.38 | -14.37 | 5.12 | -1.63 | -0.55 | -12.94 |
Free Cash Flow Per Share | -0.02 | -0.03 | 0.01 | -0.00 | -0.00 | -0.04 |
Gross Margin | -15.95% | 6.31% | 20.11% | 17.13% | -5.01% | -19.75% |
Operating Margin | -58.44% | -20.73% | -0.44% | -7.18% | -23.89% | -47.27% |
Profit Margin | -133.65% | -95.58% | 0.80% | -11.54% | -25.60% | -35.98% |
Free Cash Flow Margin | -35.42% | -22.80% | 5.21% | -1.67% | -0.81% | -33.36% |
EBITDA | -22.05 | -11.44 | 1.31 | -4.78 | -14.36 | -17.18 |
EBITDA Margin | -54.32% | -18.16% | 1.33% | -4.87% | -21.20% | -44.31% |
D&A For EBITDA | 1.67 | 1.62 | 1.74 | 2.26 | 1.83 | 1.15 |
EBIT | -23.73 | -13.06 | -0.43 | -7.03 | -16.19 | -18.33 |
EBIT Margin | -58.44% | -20.73% | -0.44% | -7.18% | -23.89% | -47.27% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.